Pictured: Prof David Lloyd, MTPConnect Chair Sue MacLeman and MTAA CEO Ian Burgess at the launch of BioMedTech Horizons in April 2018.
A novel strategy with a personalised bone-ligament-bone graft using 3D printed biocompatible scaffolds is set to create positive results for sufferers of Scapholunate Interosseous Ligament (SLIL) injury, the most common of wrist ligament injuries.
SLIL injuries cause dislocation of scaphoid and lunate bones and can be career-ending for an athlete and result in long-term disability for others. Typically, SLIL injuries are surgically treated, but have poor prognosis, with patients developing functional limitations and severe hand/wrist osteoarthritis, which impairs long-term health and imposes substantial economic burden. This project will support pre-clinical research and development to enable Orthocell to start human clinical trials, seek regulatory approval and commercialise.
Visit Griffith University for more details.
LinkedIn: Griffith University
|Consortium Lead:||Griffith University|
|Consortium Partners:||Orthocell, University of Western Australia & University of Queensland|
|Contact:||Professor David Lloyd, Research Lead, Chair of Gold Coast Orthopaedics Research & Education Alliance at Griffith University - firstname.lastname@example.org|
Professor Randy Bindra, Professor of Orthopaedic Surgery - email@example.com